Compare Baker Hughes Co (BKR) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baker Hughes Co vs Novavax Inc — how do they compare? Baker Hughes Co trades at $64.83 (market cap $63.60B), while Novavax Inc trades at $7.95 (market cap $1.30B). The key difference: Baker Hughes Co is far larger — about 48.9× Novavax Inc's market cap, and Baker Hughes Co pays a 1.44% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| BKR | NVAX | |
|---|---|---|
Market Cap | $63.60B | $1.30B |
Sector | Energy | Health |
52-Week High | $69.67 | $11.19 |
52-Week Low | $42.51 | $6.22 |
Enterprise Value | $64.13B | $879.40M |
Dividend Yield | 1.44% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Baker Hughes Co
Baker Hughes is a global leader in oilfield services and oilfield equipment, with particularly strong presences in the artificial lift, specialty chemicals, and completions markets. The other half of its business focuses on industrial power generation, process solutions, and industrial asset management, with high exposure to the liquid natural gas market specifically, as well as broader industrials end markets.
Read more on BKR →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
